Safety and Efficacy of Galvus in Elderly Type 2 Diabetes Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

431

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Vildagliptin

vildagliptin 50mg bid

DRUG

Placebo

Placebo 50mg bid

Trial Locations (46)

1431

Novartis Investigative Site, Sofia

Novartis Investigative Site, Sofia

1501

Novartis Investigative Site, Buizingen

2700

Novartis Investigative Site, Blagoevgrad

3600

Novartis Investigative Site, Genk

3945

Novartis Investigative Site, Oostham

4001

Novartis Investigative Site, Plovdiv

5800

Novartis Investigative Site, Pleven

6400

Novartis Investigative Site, Dimitrovgrad

7700

Novartis Investigative Site, Mouscron

9002

Novartis Investigative Site, Varna

9260

Novartis Investigative Site, Wichelen

9810

Novartis Investigative Site, Nazareth

9840

Novartis Investigative Site, De Pinte

10115

Novartis Investigative Site, Berlin

11540

Novartis Investigative Site, Sanlúcar de Barrameda

14469

Novartis Investigative Site, Potsdam

14612

Novartis Investigative Site, Falkensee

15110

Novartis Investigative Site, Lahti

39112

Novartis Investigative Site, Magdeburg

46600

Novartis Investigative Site, Alzira

48143

Novartis Investigative Site, Münster

58300

Novartis Investigative Site, Wetter

59269

Novartis Investigative Site, Beckum

66333

Novartis Investigative Site, Völlkingen

82291

Novartis Investigative Site, Mammendorf

92101

Novartis Investigative Site, Pie¿¿any

92237

Novartis Investigative Site, Sulzbach-Rosenberg

96050

Novartis Investigative Site, Bamberg

96215

Novartis Investigative Site, Lichtenfels

00180

Novartis Investigative Site, Helsinki

FIN-90100

Novartis Investigative Site, Oulu

06295

Novartis Investigative Site, Eisleben Lutherstadt

811 02

Novartis Investigative Site, Bratislava

03491

Novartis Investigative Site, Ľubochňa

934 01

Novartis Investigative Site, Levice

940 01

Novartis Investigative Site, Nové Zámky

040 22

Novartis Investigative Site, Košice

034 01

Novartis Investigative Site, Ružomberok

03114

Novartis Investigative Site, Alicante

08540

Novartis Investigative Site, Centelles

TR1 3LJ

Novartis Investigative Site, Truro

B9 5SS

Novartis Investigative Site, Birmingham

EX2 5DW

Novartis Investigative Site, Exeter

SG1 4AB

Novartis Investigative Site, Stevenage

SN15 2SB

Novartis Investigative Site, Wiltshire

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY